Latest News

BOSTON, Oct. 23, 2024 /PRNewswire/ -- Nemdx, Inc. today announced a poster presentation at the 2024 Northeast ALS Annual Conference (NEALS) hosted online on October 21-24. The poster, presented by Vito Levi D'Ancona, president of Nemdx, will feature amyotrophic lateral sclerosis (ALS) research, including findings ...

Zixi's executive team has also invested in the company to help drive it toward the next stages of growth BY JENNY PRIESTLEY PUBLISHED: JUNE 13, 2024 ⋅ UPDATED: JUNE 14, 2024   Live video transport provider Zixi has received what it describes as a “significant investment” from Boston-based private equity ...

Both Companies will Be merged Under the XRHealth Brand Name and By the End of the Year Are Forecasted to Have over 500K VR Treatments, Exceed 25K Patients Treated, and Be Deployed by Over 2500 Clinicians BOSTON and BARCELONA, Spain and TEL AVIV, Israel, April 18, 2023 /PRNewswire/ -- XRHealth, a Boston-based ...

NEW YORK – Variantyx said Tuesday that it has secured $20 million in debt financing from Kreos Capital. The genomic analysis company plans to use the additional cash to grow in the North American and European precision medicine markets, particularly in cancer. Framingham, Massachusetts-based Variantyx offers a ...

NEW YORK – Verizon, Bloomberg Media, Zixi and Amazon Web Services (AWS) are working together to test how 5G and mobile edge computing can transform how global business news is produced, delivered and consumed. Using Verizon 5G Edge with AWS Wavelength, Bloomberg Media will be able to package and deliver live 4K ...

FRAMINGHAM, Mass., Feb. 14, 2022 /PRNewswire/ -- Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, today announced they have secured $41.5M in funding. The series C-2 funding round, led ...

Bobby Carlton in News HTC is bringing physical therapy, occupational therapy, and pain management treatments to the metaverse. HTC VIVE is partnering with XRHealth to bring healthcare into the metaverse in the form of virtual medical rooms where patients can receive physical therapy, occupational therapy, and ...

BEDFORD Mass. – January 4, 2022 – Verseau Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for its lead investigational product candidate, VTX-0811, a monoclonal antibody that binds to P-selectin glycoprotein ...

Reasons to Invest XRHealth has generated over $1 million in revenue YTD and treated over 2,000 patients. QoQ growth has been 40+% in 2021. With $20M raised to-date from crowdfunding, angel investors, AARP, VCs, and grant-making institutions, we have demonstrated success in fundraising. With this new funding ...

STUTTGART, Germany, Nov. 15, 2021 /PRNewswire/ -- Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has completed an investment in Variantyx Inc. Variantyx and Robert-Bosch Hospital join forces to improve personalized oncology treatment with plans to incorporate the ...

BEDFORD Mass. – September 7, 2021 – Verseau Therapeutics, Inc. today announced the appointment of Karen Tubridy, Pharm.D. as Chief Development Officer. Karen brings over 25 years of drug development experience within the biopharmaceutical industry. As CDO, Karen will play a leadership role in advancing ...

BOSTON, July 28, 2021 /PRNewswire/ -- XRHealth, the leader in extended reality and therapeutic applications, announces today that they received a patent to measure neck and shoulder protraction and retraction motions with AR/VR technology that are often practiced in occupational and physical therapy ...